Clinical Trial Update: A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating paclitaxel in combination with radiation therapy for locally advanced head and neck squamous cell carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Neoplasm, Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED